Infliximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naïve Patients with Crohn's Disease

BACKGROUND/AIMS: Infliximab (IFX), an antibody to tumor necrosis factor, (TNF)-α has efficacy in treating Crohn's disease (CD). However, knowledge of the potential effects of IFX on patients' immune profiles is lacking. The purpose of this study was to reveal the immunological effects of I...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kato, Kyoichi, Fukunaga, Ken, Kamikozuru, Koji, Kashiwamura, Shinichiro, Hida, Nobuyuki, Ohda, Yoshio, Takeda, Naohisa, Yoshida, Koji, Iimuro, Masaki, Yokoyama, Yoko, Kikuyama, Risa, Miwa, Hiroto, Matsumoto, Takayuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065091/
https://ncbi.nlm.nih.gov/pubmed/21461070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2011.5.1.37
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia